Introduction
Fanconi anemia (FA)' is an autosomal recessive disorder characterized by pancytopenia, physical anomalies, and susceptibil-ity to malignancy (1) . Most patients are diagnosed in the first decade of life and die as young adults, usually from complications of severe bone marrow failure or, more rarely, from the development of acute leukemia or solid tumors. Therapy is currently limited to allogeneic bone marrow transplantation from a histocompatible sibling, but most patients do not have an appropriate marrow donor (2) .
Although the biochemical defect in FA has not been delineated, several lines of evidence implicate a defect of DNA repair. Cells derived from FA patients exhibit a marked increase in the number of spontaneous chromosomal aberrations compared to cells from normal individuals (3, 4) . Chromosomal breakage is enhanced when FA cells are incubated in the presence of the DNA cross-linking agents mitomycin C (MMC) and diepoxybutane (DEB) (5, 6) . Hypersensitivity to these agents is also reflected by delayed transit through the G2 phase of the cell cycle (7) and by accelerated cell death (8) . Chromosomal breakage, abnormal cellular sensitivity to DNA damage, and aberrant cell cycle kinetics are features which link FA nosologically with other DNA repair disorders such as xeroderma pigmentosum, ataxia telangiectasia, and Bloom's syndrome.
Somatic cell fusion methods have established that at least four different genes can cause FA (9) . A novel gene termed FACC (Fanconi anemia C complementing) has been identified by functional complementation cloning (10) . This gene, which maps to chromosome 9q, shares no homology to any known gene. The FACC protein has a predicted molecular weight of 63 kD. FACC mutations have been identified in -15% of all FA patients (11, 12) . In tissue culture, transfected FACC cDNA corrects the phenotypic defect, resulting in normalized cell growth in the presence of MMC or DEB (10) . Because [13] [14] [15] . In the absence of helper virus, AAV can persist as an integrated provirus in susceptible cells. Unlike other viruses, wild-type AAV is unique in that it integrates preferentially at a specific locus on chromosome 19q (16) (17) (18) . Virtually any mammalian cell line can be productively or latently infected. Despite its broad host range, no disease has been associated with AAV in human or animal populations suggesting that AAV would be an attractive alternative to other established viral vec- tors.
We previously demonstrated the utility of rAAV as a gene transfer vector for the human gamma globin gene into the eryth-roleukemia cell line, K562 (19) . Further studies have used this vector to characterize cis-acting elements required for globin expression (20) . Suppression of HIV-1 gene expression and replication has been documented in lymphoid cell lines using a rAAV vector carrying HIV-1 antisense sequences (21) . In addition, rAAV transduction of primary hematopoietic progenitors has been demonstrated using marker genes (22, 22a) . The self-selecting growth advantage that the FACC gene confers allows for a functional assay to test gene transduction in FA (C) hematopoietic progenitor cells. We report the first demonstration of rAAV vector transduction of human FA(C) hematopoietic cells and correction of the FACC phenotype.
Methods
Viruses and cells. Human adenovirus type 5 was obtained from the American Type Culture Collection (Rockville, MD). Epstein-Barr virus (EBV) transformed lymphoblast cell lines were generous gifts from Dr. Christopher Mathew (UMDS Guy's Hospital, London, UK) (BDO215) and Dr. Manuel Buchwald (Hospital for Sick Children, Toronto, Canada) (HSC536). All lymphoblasts were grown as previously described (10) . Detroit 6 (D6) and 293 cells were maintained as previously described (19) .
Plasmids and DNA. Plasmids pAAV/Ad, psub 201, and pUC008/ NeoR have been previously described (19, 23 Construction of rAAVplasmids. The FACC cDNA was excised from the plasmid pFAC3 after digestion with SalI. This fragment was then subcloned into the SalI site of pUC19 (New England Biolabs, Beverly, MA). To remove the FACC 3' untranslated region, the pUC 19 intermediate was digested with restriction enzymes XbaI (located at the stop codon of the FACC coding region) and NheI. These fragment ends were religated within the pREP4 polylinker, with the trimmed FACC lying between the RSV promoter and the SV40 polyadenylation site.
The trimmed version of the FACC cDNA within the expression cassette derived from pREP4 was then subcloned into the SalI site of pUC008/ NeoR. The RSV-driven FACC cDNA and the TK-driven neomycin phosphotransferase gene were then excised from pUC008/NeoR with NheI and inserted into the XbaI site of psub201 to create pAAV/FACC/ Neo R.
Generation of rAAV. Recombinant AAV were generated as previously described (19 Analysis oflymphoblast FACC expression. RNA was extracted from transduced lymphoblasts as described ( 19). 1.0 tg of RNA was reverse transcribed using the RNA PCR reagent kit (Perkin-Elmer Corp., Norwalk, CT). The cDNA sample was amplified using standard conditions Immune complexes bound to protein A sepharose CL-4B (Pharmacia, Piscataway, NJ) were washed twice with 1% Triton X-100 and 0.1% SDS, and electrophoresed on a 10% SDS/polyacrylamide gel.
Isolation of CD34+ hematopoietic cells. Apheresis was performed after obtaining written informed consent from patients enrolled on a protocol approved by the National Heart, Lung, and Blood Institute Institutional Review Board. Peripheral blood (PB) cells were collected on a Fenwall CS3000 Blood Cell Separator. Mononuclear cells were obtained following Ficoll density gradient centrifugation and immunoselected on a Ceprate LC cell separation system (Cell Pro, Inc., Bothell, WA). Cells were incubated with a mouse IgM anti-human CD34, washed, and then incubated with a biotinylated goat anti-mouse IgM antibody. Cells were filtered through an avidin column and adsorbed cells eluted. rAAV CD34+ cell transduction and CFU-C assay. CD34+ immunoselected cells were cultured at a density of 6 x 104 or 6 x 105 per ml in IMDM, 15% fetal calf serum containing 20 ng/ml human interleukin-3 (IL-3, donated by Dr. Robert E. Donahue, Hematology Branch, NHLBI), 100 ng/ml human stem cell factor (SCF; Amgen Inc., Thousand Oaks, CA), and 50 ng/ml human interleukin 6 (IL-6, donated by Dr. Robert E. Donahue). rAAV lysate was added to maintain a multiplicity of infection of 0.1. Cells were incubated overnight, spun down and resuspended in fresh media and viral lysate. This protocol was repeated for 3 d. Mock-infected cells grown only in media and colony stimulating factors served as controls.
After infection, 1 X 105 cells were plated in 3.0 ml methylcellulose (Terry Fox Labs, Vancouver, Canada) supplemented with SCF (100 ng/ml), IL-3 (20 ng/ml), IL-6 (50 ng/ml), and recombinant human erythropoietin (3 U/ml). Of this 3.0 ml mixture, 1.0 ml was plated in colony culture petri dishes (Nunc 20 il of the cDNA generated was amplified using the manufacturer's recommended conditions and included P32dCTP (800 Ci/mmol, Amersham Corp.). Primers mentioned previously were used for amplification. The conditions for amplification included: 95°C for 2 min, followed by 35 cycles at 95°C for 1 min, 60°C for 1 min, and 72°C for 2 min, followed by extension at 72°C for 8 min. PCR-generated products were run on 5% polyacrylamide gels and autoradiographed. a T to C transition leading to an amino acid substitution of leucine to proline (designated L554P). This mutation completely abolishes the activity of the FACC protein in functional assays (26 .. ilk propidium iodide staining and flow cytometry (Fig. 4 , Table  II ). used diagnostically for evaluation of patients (27, 28) . The major effect of MMC on DNA flow histograms was the expected increase in the number of cells in G2 (see Fig. 4 ). Cell cycle analysis of lymphoblasts derived from a normal individual in the absence and presence of MMC (100 nM) indicated only a modest increase (8%) in the number of cells delayed in G2 phase (Fig. 4 , A and B, and Table II) . A marked delay in G2 transit was observed when the parental lymphoblast cell line BD0215 was incubated with MMC ( Fig. 4, C and D) . The percentage of cells in G2 increased from 16 to 41% (Table II) . In marked contrast, cells from the rAAV-transduced FA line showed normalized cycle kinetics in both the absence or presence of MMC (Fig. 4 , E and F, and Table II) . No significant change in the number of cells in S phase was observed at the concentration of MMC tested (shown in Table II ). Structure and expression of the FACC gene in rAAV transduced lymphoblasts. rAAV-transduced cells selected in G418 were pooled and characterized by Southern blot analysis of genomic DNA. Shown in Fig. 5 are Southern analyses of DNAs from rAAV/FACC/NeoR transduced cells hybridized with a probe recognizing a fragment of the neomycin phosphotransferase gene. Digestion with SnaBI, which cuts within the termini, resulted in a single DNA band of predicted length, consistent with unrearranged integration of the provirus.
A reverse transcription (RT)-PCR assay was performed to determine the relative level of expression from both the transduced and endogenous FACC coding sequences. PCR primers, specific for the 3' untranslated sequences of the proviral and native FACC mRNAs, were designed to generate a 602-bp or a 486-bp product from the endogenous or transduced FACC gene, respectively. Total RNA isolated from lymphoblasts was reverse transcribed and the cDNA used for the PCR amplification (Fig. 6 ). An mRNA signal for the endogenous FACC product was obtained from mock-infected HSC536 cells. As expected, no mRNA signal was observed using primers for the transduced FACC gene. However, both the endogenous and proviral mRNAs were amplified from lymphoblasts transduced with rAAV/FACC/NeoR. FACC protein expression in normal, parental BD0215, and transduced BD0215/rAAV lymphoblasts was analyzed by immunoprecipitation (Fig. 7) . The rabbit polyclonal antiserum used was generated from an epitope of a glutathione S-transferase (GST)-FACC fusion protein directed to the carboxy terminus of FACC (amino acids 281-558). The predicted 63-kD FACC protein was detected in both normal and transduced cell phologically, the majority of colonies were of the myeloid/ macrophage lineage (CFU-GM).
RT-PCR analysis was used to verify that the MMC progenitor colonies were transduced by rAAV. Apparent MMC-resistant colonies were isolated; total RNA was obtained and analyzed by RT-PCR using conditions described in Methods. The autoradiograph in Fig. 9 demonstrated the appropriate 486-bp size fragment in 6 of 9 colonies assayed. RNA not reverse transcribed generated no signal and ruled out the possibility of DNA contamination. Analysis of additional colonies demonstrated that 60% of colonies yielded the expected 486-bp signal without detectable contaminating DNA (data not shown). Although the majority of colonies scored positive for rAAC/ FACC expression, some colonies did not express FACC as determined by our RT-PCR assay. RT-PCR results using /3-actin primers generated the appropriate signal in all of the FA(C) colonies analyzed (data not shown).
Discussion
We have shown that a recombinant AAV vector can transfer a functioning copy of the normal FACC gene to FA(C) lymphoblasts and CD34+ hematopoietic progenitors, correcting the phenotypic defect of these cells. FACC mutations known to result in the disease phenotype. Using PCR analysis, the level of rAAV/FACC expression appeared to be equivalent to that of the endogenous gene. Transduced lymphoblasts maintained a corrected phenotype over more than 50 cell passages without selection, consistent with stable proviral integration. Of importance to the application of (31) . Transduction was determined solely from the number of geneticin-resistant bone marrow colonies. These early generation rAAV preparations were contaminated with wild type AAV virions which decreased rAAV transduction efficiency (13) .
We have focused on the use of packaging systems which generate rAAV stocks devoid of wild type virions (23 Role of FACC in hematopoiesis. In vitro culture assays of hematopoiesis in FA patients have consistently shown a reduction or absence of colony forming progenitor cells (CFU-C) of all hematopoietic lineages (32, 33) . Long-term bone marrow culture experiments, which require the development of an adherent stromal cell layer for the maintenance of progenitor growth, have also revealed a significant reduction in the number of CFU-C (34). Although defects of the bone marrow stromal elements cannot be totally excluded, fibroblasts (a major cell constituent of the stroma) from FA patients seem to express the appropriate repertoire of hematopoietic growth factors (35). Available evidence suggests, therefore, that FA is a disorder of a primitive hematopoietic stem cell. We have been able to show that CD34+ progenitors from a FA(C) patient retain the hypersensitivity to MMC which characterizes cultured FA cells.
In this study, we utilized the unique characteristics of the FACC gene to serve as a biological marker for rAAV/FACC gene transfer. As we demonstrated with rAAV-transduced FA(C) lymphoblasts, expression of the FACC gene in FACCdeficient cells promotes cell growth in the presence of MMC. The self-selecting growth advantage conferred by expression of the FACC gene was also evident from the results obtained following the incubation of virally transduced FA(C) progenitor cells with low dose MMC (1 nM), a dose which has no effect on colony growth of CD34+ cells from normal individuals. FA cells are markedly retarded during progression through the G2 phase of the cell cycle (7, 40) . rAAV-transduced FA lymphoblasts were phenotypically corrected not only in terms of MMC-induced cell survival and chromosomal aberrations but also demonstrated normalized cell cycle kinetics. At least two periods in the cell cycle are regulated in response to DNA damage, the G1-S and G2-M transitions. These "checkpoints" function as surveillance mechanisms which delay cell cycle progression and allow for the repair of damaged DNA. Both G1 and G2 checkpoints are known to be under genetic control (41) 
